Add-on Acquisition • Life Science

Northwest Biotherapeutics Acquires Advent Bioservices

On August 27, 2025, Northwest Biotherapeutics acquired life science company Advent Bioservices

Acquisition Context

This is Northwest Biotherapeutics’ 1st transaction in the Life Science sector.
This is Northwest Biotherapeutics’ 1st transaction in the United Kingdom.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	August 27, 2025
Target	Advent Bioservices
Sector	Life Science
Buyer(s)	Northwest Biotherapeutics
Deal Type	Add-on Acquisition

Target Company

Advent Bioservices

Cambridge, United Kingdom

Advent Bioservices is a cell therapy Contract Development & Manufacturing Organisation (CDMO) that manages the development of a state-of-the-art facility for multiproduct Good Manufacturing Practice (GMP) production outside Sawston in Cambridgeshire, which will allow scale-up of current commercial production and initiate the provision of contract manufacturing services to meet the growing demand for such services in the UK. Advent Bioservices was formed in 2016 and is based in Cambridge, United Kingdom.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer